![Hedi Brahim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hedi Brahim
Direktor/Vorstandsmitglied bei
GENEURO SA
Profil
Hedi Ben Brahim currently works at One Biosciences SAS, as Chief Executive Officer from 2023, Institut Mérieux SA, as Operational Director- Immunotherapy Division from 2018, Transgene, Inc., as Director, Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd., as Director, and GeNeuro SA (Switzerland), as Independent Director from 2020.
Mr. Brahim also formerly worked at Vallourec Drilling Products France SAS, as Chief Executive Officer-Europe Africa Division, Advanced BioScience Laboratories, Inc., as Chairman, Fabentech SAS, as Chairman-Supervisory Board, Transgene SA, as Director in 2023, Vallourec SA, as Vice President-Corporate Planning, VAM USA LLC, as General Manager-Production, and France Ministry of Labor, Social Affairs, Family & Solidarity, as Head-Health Products.
Mr. Brahim received his undergraduate degree from École Nationale Supérieure des Mines de Paris.
Aktive Positionen von Hedi Brahim
| Unternehmen | Position | Beginn |
|---|---|---|
| GENEURO SA | Direktor/Vorstandsmitglied | 27.05.2020 |
Transgene, Inc.
 Transgene, Inc. BiotechnologyHealth Technology Founded in 1982, Transgene, Inc. is a clinical-stage biotechnology company specializing in cancer immunotherapy through viral vector engineering. The company is based in Dover, DE. The company develops individualized therapeutic vaccines using its proprietary myvac® platform, which designs personalized vaccines targeting tumor-specific neoantigens to stimulate the patient’s immune system against early-stage solid tumors. Its lead product, TG4050, is an individualized neoantigen vaccine in randomized phase 1/2 trials as an adjuvant treatment for HPV-negative head and neck squamous cell carcinoma. Transgene’s pipeline also includes oncolytic virus candidates BT-001 and TG6050, engineered to express immune-modulating antibodies and cytokines, evaluated in early-phase clinical trials for various solid tumors. | Direktor/Vorstandsmitglied | - |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Direktor/Vorstandsmitglied | - |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Corporate Officer/Principal | 01.09.2018 |
One Biosciences SAS
 One Biosciences SAS BiotechnologyHealth Technology Provides single-cell technology research and development services | Vorstandsvorsitzender | 07.09.2023 |
Ehemalige bekannte Positionen von Hedi Brahim
| Unternehmen | Position | Ende |
|---|---|---|
| TRANSGENE | Vorstandsvorsitzender | 01.06.2023 |
Advanced BioScience Laboratories, Inc.
 Advanced BioScience Laboratories, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization dedicated to advancing therapeutics, vaccines & biological products | Vorsitzender | 01.01.2023 |
Fabentech SAS
 Fabentech SAS Medical/Nursing ServicesHealth Services Developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. | Vorsitzender | 01.01.2021 |
France Ministry of Labor, Social Affairs, Family & Solidarity
 France Ministry of Labor, Social Affairs, Family & Solidarity General GovernmentGovernment Oversees social welfare policy | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Hedi Brahim
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
38
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Vallourec SA
 Vallourec SA SteelNon-Energy Minerals Manufactures and distributes steel and alloy tubing used by the automobile, oil and gas refining, petrochemical and other industries | Non-Energy Minerals |
École Nationale Supérieure des Mines de Paris
 École Nationale Supérieure des Mines de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced BioScience Laboratories, Inc.
Advanced BioScience Laboratories, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization dedicated to advancing therapeutics, vaccines & biological products | Health Technology |
VAM USA LLC
 VAM USA LLC Wholesale DistributorsDistribution Services Supplies threaded connections for oil and gas industry | Distribution Services |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Health Technology |
Transgene, Inc.
Transgene, Inc. BiotechnologyHealth Technology Founded in 1982, Transgene, Inc. is a clinical-stage biotechnology company specializing in cancer immunotherapy through viral vector engineering. The company is based in Dover, DE. The company develops individualized therapeutic vaccines using its proprietary myvac® platform, which designs personalized vaccines targeting tumor-specific neoantigens to stimulate the patient’s immune system against early-stage solid tumors. Its lead product, TG4050, is an individualized neoantigen vaccine in randomized phase 1/2 trials as an adjuvant treatment for HPV-negative head and neck squamous cell carcinoma. Transgene’s pipeline also includes oncolytic virus candidates BT-001 and TG6050, engineered to express immune-modulating antibodies and cytokines, evaluated in early-phase clinical trials for various solid tumors. | Health Technology |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. | Health Services |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | |
Vallourec Drilling Products France SAS
 Vallourec Drilling Products France SAS Oilfield Services/EquipmentIndustrial Services Manufactures and supplies drilling products | Industrial Services |
France Ministry of Labor, Social Affairs, Family & Solidarity
France Ministry of Labor, Social Affairs, Family & Solidarity General GovernmentGovernment Oversees social welfare policy | Government |
GeNeuro SA (Switzerland)
 GeNeuro SA (Switzerland) BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products to treat neurological diseases | Health Technology |
One Biosciences SAS
One Biosciences SAS BiotechnologyHealth Technology Provides single-cell technology research and development services | Health Technology |
